Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors

Details Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors

1992-04-03

1994-09-20

Daus, Donald G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514374, 548110, 548232, 548235, 548236, A61K 3142

Patent

active

053489691

ABSTRACT:
A novel series of oxazole derivatives having enhanced water solubility bioavailability and metabolic stability is disclosed in the Formula I ##STR1## Y is CH.sub.3, Ph, or OH, provided that when Y is OH, the compound exists in the keto-enol tautaumerism form ##STR2## R.sup.1 is Ph or Th; R.sup.2 is H or CH.sub.2 R.sup.3 ;

REFERENCES:
patent: 3578670 (1971-05-01), Brown
patent: 4105790 (1978-08-01), Hughes et al.
patent: 4460598 (1984-07-01), Lautenschlager et al.
patent: 4659728 (1987-04-01), Lewis et al.
patent: 4774253 (1988-09-01), Machin et al.
patent: 4785012 (1988-11-01), Crews et al.
patent: 4791124 (1988-12-01), Lutomski et al.
patent: 4880804 (1989-11-01), Carini
patent: 5011851 (1991-04-01), Meanwell et al.
patent: 5071988 (1991-12-01), Failli et al.
patent: 5262540 (1993-11-01), Meanwell
Aldous et al. J. Org. Chem. vol. 25 pp. 1151-1154 (1960).
Lautenschlager, et al., Drugs of the Future, 11, 26 (1986).
Moncoda, et al., Nature, 263, 663 (1976).
Nickolson, et al., Med. Res. Rev., 5, 1 (1985).
Seiler, et al., J. Pharmacol. Exp. Ther., 255: 1021 (1990).
T. Shioiri, Y. Hamada, Heterocycles, 27: 1035: (1988).
Wasserman, et al., Chem. Rev., 86: 845 (1986).
G. D. Hartman, L. M. Weinstock, Org. Syn., VI, 620 (1988).
J. L. Kraus, Synth. Comm., 16:827 (1986).
J. F. W. McOmie, M. L. Watts, Chem. Ind., 1658 (1963).
Negishi et al., J. Org. Chem., 42: 1821 (1977).
Wasserman, et al., Tetrahedron Lett., 22: 1737 (1981).
R. F. Abdulla, R. S. Brinkmeyer, Tetrahedron, 35: 1675 (1979).
A. P. Kozikowski, A. J. Ames, J. Org. Chem., 45: 2548 (1980).
Moriya, et al., J. Med. Chem., 29: 333 (1986).
D. Hoppe, Angew. Chem., Int. Ed., 13:789 (1974).
J. Frump, Chem. Rev., 71:483 (1971).
H. Eckert, B. Forster, Angew. Chem., Int. Ed., 26:894 (1987).
Suzuki, et al., J. Org. Chem., 38:3571-3575 (1973).
H. Reimlinger, Chemistry and Industry, 1082-1083 (1970).
Davidson, et al., J. Org. Chem., 2:319 (1937).
I. Yamawaki, K. Ogawa, Chem. Pharm. Bull., 36:3142 (1988).
Meanwell, et al., J. of Med. Chem., 35:389-397 (1992).
Merritt, et al., Br. J. Pharmacol., 102:260-266 (1991).
Merritt, et al., Br. J. Pharmacol., 102:251-259 (1991).

Affiliated with

Also associated with

Rating

Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2429898